provision
FDA Crackdown on Pharma TV Ads Targets Pfizer, Novartis, BMS, Lilly & Others
FDA crackdown; pharma TV ads; Pfizer; Novartis; BMS; Lilly; warning letters; direct-to-consumer advertising; adequate provision rule; drug marketing compliance
Actionable Insights Powered by AI
FDA crackdown; pharma TV ads; Pfizer; Novartis; BMS; Lilly; warning letters; direct-to-consumer advertising; adequate provision rule; drug marketing compliance